Aller au contenu
Capteurs et mesuresÉtude transversale3 min read

Adults with any chronic disease did less moderate and vigorous activity in UK Biobank

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Physical activity of UK adults with chronic disease: cross-sectional analysis of accelerometer-measured physical activity in 96 706 UK Biobank participants. · International journal of epidemiology · 2019 · Article original ↗

À retenir

Among 96 706 UK Biobank participants aged 40 or older, people with chronic disease did 9% (61 minutes; 95% CI, 57.8-64.8) less moderate activity and 11% (3 minutes; 95% CI, 2.7-3.3) less vigorous activity per week than people without. This is a snapshot, so it cannot tell whether disease reduces activity or low activity contributes to disease.

Study design

Étude transversale

Reading basis

Published abstract

Reading focus

Association & confounding

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Inactivity raises the risk of major chronic diseases, but it is less clear which chronic diseases themselves lead people to be less active. The authors compared accelerometer-measured physical activity in people with and without chronic disease.

Population et méthode

Cross-sectional analysis of 96 706 participants aged 40 years or older from the UK Biobank prospective cohort (2006-10). Diagnoses were identified from ICD 9 and 10 codes in linked hospital admission records and a cancer registry. Physical activity came from a wrist-worn triaxial accelerometer worn for 7 days. Adjusted geometric means and means were computed with general linear models.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    People with chronic disease did 9% or 61 minutes less moderate activity per week (95% CI, 57.8-64.8) than people without chronic disease.
  2. 2
    They also did 11% or 3 minutes less vigorous activity per week (95% CI, 2.7-3.3).
  3. 3
    Every chronic-disease subgroup was less active than people without chronic disease, and 67 individual diagnoses were associated with lower moderate activity.

Limites et incertitude

  1. 1
    Cross-sectional design: activity was measured at one point, after diagnoses were already recorded, so the direction of the link is unknown.
  2. 2
    Diagnoses came from hospital and cancer registry records, so people treated only outside hospital may be counted as having no chronic disease.
  3. 3
    Only one 7-day accelerometer period per person, and the abstract does not say how adjustment variables were chosen or how many people wore the device.
  4. 4
    This reading is based on the abstract only.

Mise en perspective

People living with a chronic condition tend to move less, across the whole range of conditions studied. The authors note that this means such patients face extra risk from inactivity on top of their disease. Whether and how to become more active with a condition is a decision to make with your clinician.

Vos données

Wrist-worn accelerometer data like yours (active minutes, moderate and vigorous minutes) are the same kind of measure used here. Compare your own weeks on the same device, and remember that on-device intensity thresholds differ from the study's.

Comprendre ce type de preuve

Measurements are taken in the same period. Direction and causation usually cannot be determined; symptoms can change behaviour as well as the reverse.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Physical inactivity is associated with an increased risk of major chronic diseases, although uncertainty exists about which chronic diseases, themselves, might contribute to physical inactivity. The objective of this study was to compare the physical activity of those with chronic diseases to healthy individuals using an objective measure of physical activity.

Methods

We conducted a cross-sectional analysis of data from 96 706 participants aged 40 years or older from the UK Biobank prospective cohort study (2006-10). Diagnoses were identified through ICD 9 and 10 coding within hospital admission records and a cancer registry linked to UK Biobank participants. We extracted summary physical activity information from participants who wore a wrist-worn triaxial accelerometer for 7 days. Statistical analyses included computation of adjusted geometric means and means using general linear models.

Results

Participants with chronic disease undertook 9% or 61 minutes (95% confidence interval: 57.8-64.8) less moderate activity and 11% or 3 minutes (95% confidence interval: 2.7-3.3) less vigorous activity per week than individuals without chronic disease. Participants in every chronic-disease subgroup undertook less physical activity than those without chronic disease. Sixty-seven diagnoses within these subgroups were associated with lower moderate activity.

Conclusions

The cross-sectional association of physical activity with chronic disease is broad. Given the substantial health benefits of being physically active, clinicians and policymakers should be aware that their patients with any chronic disease are at greater health risk from other diseases than anticipated because of their physical inactivity.

Sources et attribution

Physical activity of UK adults with chronic disease: cross-sectional analysis of accelerometer-measured physical activity in 96 706 UK Biobank participants.

Barker J, Smith Byrne K, Doherty A, Foster C, Rahimi K, Ramakrishnan R, Woodward M, Dwyer T.

International journal of epidemiology · 2019-08-01

DOI: 10.1093/ije/dyy294 ↗PubMed · 30721947 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Étude de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explications approfondiesLire l’étude →
·Validation : étude/revue

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explications approfondiesLire l’étude →
·Synthèse de revues

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explications approfondiesLire l’étude →
·Validation : étude/revue

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explications approfondiesLire l’étude →
Capteurs et mesures →